The vision of The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs) is to become a leader in the field of human immunology by establishing an environment where basic, translational and clinical aspects of human immunology and immunotherapy research are seamlessly integrated. We will achieve this through these primary initiatives:
- Facilitate basic research in the new and rapidly evolving areas of human immunology;
- Use the insights that emerge from this research to achieve a better understanding of human disease; and,
- Provide an environment that encourages and supports the clinical translation of these insights into novel therapies for autoimmunity, cancer, immunodeficiency and infectious diseases.
COVID-19 IML Update
The Immunomonitoring Lab is now fully open.
Please be sure to follow all current WashU COVID-19 procedures.
CHiiPs Faculty Membership
As a member of CHiiPs, you have full access to the Immunomonitoring Lab (IML), experts in cytometry and immunoassay production, and extensive resources; even better, CHiiPs members receive a substantial discounted rate for some of these services.
iLab User Registration
iLab is a web-based system that utilizes a user’s existing WUSTL Key login information to place requests for core lab services, schedule equipment and monitor progress of current and ongoing projects serviced by the Immunomonitoring
Lab (IML). PI approval needed for new users.
Just-In-Time (JIT) Core Usage Funding Program
New Hallmarks of Cancer ProcartaPlex Panels from Thermo Fisher Scientific
New SARS-CoV-2 Immunoassays from Thermo Fisher Scientific
ELISA and ProcartaPlex kits—measure Ig titers and neutralizing antibodies against SARS-CoV-2 wild type and variants
COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants (Links to an external site)
Every gift, no matter the size, helps supports our mission.
Thank you for your generous support!